Cargando…
Long non-coding RNA LUCAT1 contributes to cisplatin resistance by regulating the miR-514a-3p/ULK1 axis in human non-small cell lung cancer
Drug resistance is a major obstacle in the therapy of malignant tumors, including non-small cell lung cancer (NSCLC). Long non-coding RNAs (lncRNAs) have been demonstrated to be involved in chemoresistance. The present study aimed to investigate the role of lung cancer-associated transcript 1 (LUCAT...
Autores principales: | Shen, Qiming, Xu, Zhe, Xu, Shun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7473752/ https://www.ncbi.nlm.nih.gov/pubmed/32945379 http://dx.doi.org/10.3892/ijo.2020.5106 |
Ejemplares similares
-
Long non‐coding RNA LUCAT1 promotes tumourigenesis by inhibiting ANXA2 phosphorylation in hepatocellular carcinoma
por: Lou, Yun, et al.
Publicado: (2018) -
The long non-coding RNA LUCAT1 is a negative feedback regulator of interferon responses in humans
por: Agarwal, Shiuli, et al.
Publicado: (2020) -
Characterization of a Novel LUCAT1/miR-4316/VEGF-A Axis in Metastasis and Glycolysis of Lung Adenocarcinoma
por: Wang, Lishui, et al.
Publicado: (2022) -
Long non-coding RNA LUCAT1 promotes the progression of clear cell renal cell carcinoma via the microRNA-375/YAP1 axis
por: Wang, Xiaojun, et al.
Publicado: (2021) -
Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway
por: Zheng, Ang, et al.
Publicado: (2019)